CORT

As of 2026-10-26, CORT scores 47out of 100 on QNTM’s five-factor quantitative model, a moderate conviction reading. The score blends momentum, quality, volume, value and sentiment, then adjusts for the current macro regime. CORT trades at $87.13, within its fair-value band.

CORT scores 47 out of 100 on QNTM's five-factor model — a moderate reading — neither strongly favored nor flagged for weakness at 47. Its strongest factor is volume at 59 (solid), where trading volume confirms genuine accumulation, followed by value at 56. The weakest is sentiment at 36, where sentiment signals are working against it. Among Healthcare stocks it sits in the lower 38% of Healthcare names by composite.

On valuation, CORT is priced in the upper part of its recent range. The blended composite before the macro overlay was 48. Same-sector names the model rates nearby include HALO, VEEV, THC.

This is a descriptive factor read on CORT, recomputed each trading day and shown with its reasoning — not a recommendation to buy, hold or sell. The score reflects where CORT sits on the model's measures today, and can change as new data arrives.

FACTOR BREAKDOWN

VALUATION RANGE

QNTM’s descriptive fair-value band for CORT runs $53.10–$106.75. Current price $87.13 sits within its fair-value band. This is valuation context, not a price target.

OTHER HEALTHCARE NAMES

QNTM provides quantitative model outputs for informational and educational purposes only. It is not investment advice and QNTM is not a registered investment adviser. Scores are rankings, not buy/sell recommendations. Data as of 2026-10-26.